Degenerative Disc Disease Treatment Market, by Product Type (Drugs (Acetaminophen, NSAIDs, Oral Steroids, and Muscle Relaxants), Devices (Cervical Spine, Lumbar Spine, Thoracic Spine and Spinal Fusion), and by Region (North America, Latin America, Europe

Degenerative Disc Disease Treatment Market, by Product Type (Drugs (Acetaminophen, NSAIDs, Oral Steroids, and Muscle Relaxants), Devices (Cervical Spine, Lumbar Spine, Thoracic Spine and Spinal Fusion), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Degenerative disc disease is a spinal condition caused by the breakdown of intervertebral discs. The symptoms observed for degenerative disc disease are tingling or numbness in legs or difficulty walking. This disease is diagnosed with physical examination, through X-rays or magnetic resonance imaging (MRI). The degenerative disc disease is most commonly seen in geriatric population and have caused low back pain and neck pain in adults. The common cases of back pain among patients occurs at the lower side of the back. As per American Association of Neurological Surgeons in 2016, 75-85% of the people in the U.S. experience some form of back pain in their life.

Market Dynamics

Increasing prevalence of degenerative disc disease is expected to support the market growth over the forecast period. For instance, according to the National Center for Biotechnology Information report, around 266 million patients worldwide were diagnosed with lumbar degenerative spine disease (DSD) in 2018.

However, high cost associated with degenerative disc disease treatments such as artificial disc replacement and spinal fusion is expected to hamper the market growth in the near future. For instance, the average cost of specific disc replacement surgery procedure ranges between US$ 16,000 to US$ 46,000 in different states of the U.S.

Key features of the study:

• This report provides in-depth analysis of the global degenerative disc disease treatment market, market size (US$ Mn), and compound annual growth rate (CAGR (%) for the forecast period, 2019-2027, considering 2018 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global degenerative disc disease treatment market based on the following parameters: company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Medtronic Plc., Globus Medical Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, RTI Surgical Holdings, Inc., Cousin Biotech, Ulrich Medical USA, Inc., Fresenius Kabi AG and Abbott Laboratories
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global Degenerative Disc Disease Treatment market report caters to various stakeholders in this industry, which include investors, product manufacturers, distributors, and suppliers for global Degenerative Disc Disease Treatment market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

• Global Degenerative Disc Disease Treatment Market, by Product Type:
• Drugs
• Acetaminophen
• NSAIDs
• Oral steroids
• Muscle Relaxants
• Devices
• Cervical Spine
• Lumbar Spine
• Thoracic Spine
• Spinal Fusion
• Global Degenerative Disc Disease Treatment Market, by Region:
• North America
• By Country:
• U.S.
• Canada
• By Product Type:
• Drugs
• Acetaminophen
• NSAIDs
• Oral steroids
• Muscle Relaxants
• Devices
• Cervical Spine
• Lumbar Spine
• Thoracic Spine
• Spinal Fusion
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• By Product Type:
• Drugs
• Acetaminophen
• NSAIDs
• Oral steroids
• Muscle Relaxants
• Devices
• Cervical Spine
• Lumbar Spine
• Thoracic Spine
• Spinal Fusion
• Asia Pacific
• By Country:
• Australia
• India
• China
• Japan
• ASEAN
• South Korea
• Rest of Asia Pacific
• By Product Type:
• Drugs
• Acetaminophen
• NSAIDs
• Oral steroids
• Muscle Relaxants
• Devices
• Cervical Spine
• Lumbar Spine
• Thoracic Spine
• Spinal Fusion
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• By Product Type:
• Drugs
• Acetaminophen
• NSAIDs
• Oral steroids
• Muscle Relaxants
• Devices
• Cervical Spine
• Lumbar Spine
• Thoracic Spine
• Spinal Fusion
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• By Product Type:
• Drugs
• Acetaminophen
• NSAIDs
• Oral steroids
• Muscle Relaxants
• Devices
• Cervical Spine
• Lumbar Spine
• Thoracic Spine
• Spinal Fusion
• Africa
• By Country/Region:
• South Africa
• Central Africa
• North Africa
• By Product Type:
• Drugs
• Acetaminophen
• NSAIDs
• Oral steroids
• Muscle Relaxants
• Devices
• Cervical Spine
• Lumbar Spine
• Thoracic Spine
• Spinal Fusion
• Company Profiles
• Medtronic Plc.*
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Globus Medical Inc.
• Johnson & Johnson
• Zimmer Biomet Holdings, Inc.
• B. Braun Melsungen AG
• RTI Surgical Holdings, Inc.
• Cousin Biotech
• Ulrich Medical USA, Inc.
• Fresenius Kabi AG
• Abbott Laboratories

“*” marked represents similar segmentation in other categories in the respective section.